| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/04/2010 | US7709484 1-((2R,5S)-5-Benzyl-2-naphthalen-2-ylmethyl-piperazin-1-yl)-3-(2,4-dichloro-phenyl)-propan-1-one; melanocortin receptor-associated disorder such as cachexia, obesity, erectile dysfunction or female sexual dysfunction |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
| 05/04/2010 | US7709477 Triheterocyclic Compounds; small cell lung cancer, follicular lymphoma, non-small cell lung cancer, non-Hodgkin's disease lymphoma, or acute myelocytic leukemia |
| 05/04/2010 | US7709476 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias |
| 05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 05/04/2010 | CA2439001C Water-soluble triazole antifungal agents |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2433840C Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof |
| 05/04/2010 | CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/29/2010 | WO2010048131A1 C-met protein kinase inhibitors |
| 04/29/2010 | WO2010048016A1 2,3-disubstituted piperidine orexin receptor antagonists |
| 04/29/2010 | WO2010047296A1 NOVEL PYRIMIDINE DERIVATIVE AND METHOD FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR INTERMEDIATE |
| 04/29/2010 | WO2010047260A1 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
| 04/29/2010 | WO2010046780A2 Anti viral compounds |
| 04/29/2010 | WO2010045948A1 Isoquinolinone derivatives as nk3 antagonists |
| 04/29/2010 | WO2010020432A3 Compounds for treatment of duchenne muscular dystrophy |
| 04/29/2010 | WO2010011684A3 Prodrug and fluoregenic compositions and methods for using the same |
| 04/29/2010 | WO2009125426A3 NOVEL PROCESS FOR THE PREPARATION OF (3SM-[2-(2 J-DIHYDRO-5- BENZOFURANYLϊETHYL]-α.α -DIPHENYL-3-PYRROLIDINEACETAMIDE HYDROBROMIDE |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105914 Caspase inhibitors and uses thereof |
| 04/29/2010 | US20100105904 Urea type cinnamide derivative |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105739 Modulators of atp-binding cassette transporters |
| 04/29/2010 | US20100105727 Novel benzamide derivatives and process for the prepartion thereof |
| 04/29/2010 | US20100105726 Imidazole derivatives that induce apoptosis and their therapeutic uses |
| 04/29/2010 | US20100105719 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors |
| 04/29/2010 | US20100105694 Substituted pyrazinone derivatives for use as a medicine |
| 04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105654 Substituted quinazolinone compounds |
| 04/29/2010 | US20100105617 C-Terminal Attachment of Two Chemical Groups to Peptides |
| 04/29/2010 | CA2740583A1 C-met protein kinase inhibitors |
| 04/29/2010 | CA2740190A1 2,3-disubstituted piperidine orexin receptor antagonists |
| 04/29/2010 | CA2739946A1 Isoquinolinone derivatives as nk3 antagonists |
| 04/28/2010 | EP2180020A1 Indolium compound and optical recording material using the compound |
| 04/28/2010 | EP2178864A2 Process for the preparation of alfuzosin hydrochloride |
| 04/28/2010 | EP2178859A2 Condensed anthranilamide derivatives as insectisides |
| 04/28/2010 | EP2178841A2 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
| 04/28/2010 | EP2178837A2 Isophthalamide derivatives inhibiting beta-secretase activity |
| 04/28/2010 | EP1678162B1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | CN1872851B Compound of alpha - methylene - gamma - butyrolactone, preparation method, and method |
| 04/28/2010 | CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/28/2010 | CN1812972B Caspase inhibitors and uses thereof |
| 04/28/2010 | CN1747929B Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/28/2010 | CN1434043B Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 04/27/2010 | US7705147 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 04/27/2010 | US7705031 Benzimidazoles useful as modulators of ion channels |
| 04/27/2010 | US7705029 Acrylonitrile derivatives for inflammation and immune-related uses |
| 04/27/2010 | US7705020 Benzimidazolone carboxylic acid derivatives |
| 04/27/2010 | US7705009 4-aminopyrimidine-5-thione derivatives |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
| 04/27/2010 | US7704996 Compounds and compositions useful as cathepsin S inhibitors |
| 04/27/2010 | US7704995 Protein kinase modulators and methods of use |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | CA2563042C 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 04/27/2010 | CA2551038C Triazole derivatives as vasopressin antagonists |
| 04/27/2010 | CA2495880C Pyrimidine derivatives and their use as cb2 modulators |
| 04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 04/27/2010 | CA2311669C (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 04/22/2010 | WO2010045402A1 Trpv1 antagonists |
| 04/22/2010 | WO2010045401A1 Trpv1 antagonists |
| 04/22/2010 | WO2010045190A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010044411A1 Phenylisonicotinic acid derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044410A1 Biaryl isonicotinic acid derivative and medical application of same |
| 04/22/2010 | WO2010044404A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010043315A1 Pesticidal (hetero) arylpyrrolidines |
| 04/22/2010 | WO2010042998A1 S1p receptors modulators |
| 04/22/2010 | WO2010012442A3 Insecticidal benzenedicarboxamide derivative |
| 04/22/2010 | WO2010003624A3 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/22/2010 | WO2009125430A3 Improved process for producing darifenacin |
| 04/22/2010 | WO2009068468A3 Pyridine compounds |
| 04/22/2010 | US20100099670 Benzoquinazoline derivatives |
| 04/22/2010 | US20100099661 Antibacterial aminoglycoside analogs |
| 04/22/2010 | CA2740608A1 Pesticidal (hetero) arylpyrrolidines |
| 04/22/2010 | CA2739901A1 S1p receptors modulators |
| 04/22/2010 | CA2739488A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2739058A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2737775A1 Trpv1 antagonists |
| 04/22/2010 | CA2737768A1 Trpv1 antagonists |
| 04/21/2010 | EP2177522A1 Novel carbapenem derivatives |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177518A1 Organic compounds |
| 04/21/2010 | EP2177512A1 Inhibitor of binding of s1p1 |
| 04/21/2010 | EP2177511A2 Process for preparing 3,6-disubstituted azabicyclo derivatives |
| 04/21/2010 | EP2176253A2 A process for the preparation or purification of olmesartan medoxomil |
| 04/21/2010 | EP2176252A1 2, 3-dihydrobenzo[1, 4]dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases |
| 04/21/2010 | EP2176251A2 5-pyridinone substituted indazoles |
| 04/21/2010 | EP2176237A1 Phthalazinone derivatives as inhibitors of parp-1 |
| 04/21/2010 | EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |